Cargando…
Serum CA125 is a predictive marker for breast cancer outcomes and correlates with molecular subtypes
Detection of serum tumor markers has been developed as a non-invasive tool to assess treatment efficiency in different types of cancer. This study aims to investigate the role of preoperative serum tumor markers (CEA, CA125 and CA15-3) in the management of breast cancer, and their relationships with...
Autores principales: | Fang, Cheng, Cao, Yue, Liu, Xiaoping, Zeng, Xian-Tao, Li, Yirong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609976/ https://www.ncbi.nlm.nih.gov/pubmed/28969044 http://dx.doi.org/10.18632/oncotarget.19246 |
Ejemplares similares
-
Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden
por: Liu, Liang, et al.
Publicado: (2016) -
Preoperative serum CA125: a useful marker for surgical management of endometrial cancer
por: Jiang, Tao, et al.
Publicado: (2015) -
Correlation of Serum CA-125 and Progesterone Levels with
Ultrasound Markers in The Prediction of Pregnancy
Outcome in Threatened Miscarriage
por: Al Mohamady, Maged, et al.
Publicado: (2016) -
CA-125 is not a useful marker in metastatic breast cancer.
por: Seckl, M. J., et al.
Publicado: (1992) -
Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors
por: Lertkhachonsuk, Arb‐aroon, et al.
Publicado: (2020)